+897.3%
IREN vs THC
+244.5%
+652.8%
-65.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.3% | +0.6% | +6.7% | +7.2% |
| 7D | +26.0% | -0.7% | +26.7% | +26.1% |
| 30D | +14.9% | +1.3% | +13.6% | +14.6% |
| 3M | -27.8% | +64.2% | -92.0% | -34.8% |
| 6M | +1.9% | +8.3% | -6.4% | +0.4% |
| YTD | +18.3% | +33.4% | -15.1% | +11.3% |
| 1Y | +71.0% | +37.7% | +33.3% | +60.0% |
| All | +897.3% | +244.5% | +652.8% | +554.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling